So sell yours. As for the informed investors here, its safe to say WE will be HOLDING then adding then adding then adding , for at least the next year. Only catilist to change that is a failure of KEVETRIN in PHASE I tests. That is not likely to happen.
This is one of those rare co. that has the confidence of the market. Most small bio pharms struggle to get noticed. I put this on my watch @.65. I missed it didn't get in until September @1.10. I never worried as it went back to .85 I added. This stock already has commercial appeal. The directors already have the confidence of the market this is a no brainer. 10.00 in two years.